PIP5K1A: a potential target for cancers with KRAS or TP53 mutations

Nat Rev Drug Discov. 2020 Jul;19(7):436. doi: 10.1038/d41573-020-00067-3.

Michael P East, Tuomo Laitinen, Christopher R M Asquith

PMID: 32332925 DOI: 10.1038/d41573-020-00067-3

Products

Cat. No.

Product Name

Description

Target

Research Area
HY-E70631

PIP5K1A Recombinant Human Active Lipid Kinase

PIP5K1A Kinase

PI3K

Cancer

MedChemExpress Magic Cece

MedChemExpress: Contact Us; About Us; Headquarters; Distributors; Statement on False Report; Careers

Customer Support: Technical Support; Service; Ordering Information; Easy Return; Shipping Rates & Policies; Intellectual Property Promise

Resources: Free Sample; Resources; Molarity Calculator; Dilution Calculator; Terms & Conditions; Reconstitution Calculator; Specific Activity Calculator; DNA/RNA sequence conversion tools

Subscribe to our E-newsletter

Name
Email *

	Sorry, but the email address you supplied was invalid.

Products are chemical reagents for research use only and are not intended for human use. We do not sell to patients.

Copyright © 2013-2025 MedChemExpress. All Rights Reserved.: Site Map Privacy Policy

Join with us